Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “AMIDINES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 829 records · Page 46Linked to original sources

Differential modification of specificity in carbonic anhydrase catalysis.

Incubation of carbonic anhydrase II with acrolein results in a rapid, time-dependent loss of all but approximately 3-6% of the original catalytic activity toward CO2 hydration and HCO3- dehydration, with the inactivation rate being first-order in both acrolein and the enzyme. The pH dependence of the inactivation rate constant can be adequately described with a function incorporating a pK alpha of 7.15 and a maximal value for kinact [corrected] of 26.2 M-1 min-1, indicating that at least one of the catalytically essential residues that ionizes at this pH is involved in the modification scheme. The amount of residual CO2 hydratase activity is proportional to the molar excess of acrolein over carbonic anhydrase II with 5 histidyl and 3 lysyl residues being subject to alkylation under conditions where [acrolein] to [carbonic anhydrase II] ratio is greater than 100. Because all lysyl residues were shown previously to be amidinated without detectable loss of activity, it was assumed that the modification of one (or more) of the histidines was primarily responsible for the observed inactivation. The number of modified histidyl residues could be related to residual activity by using the statistical analysis of Tsou (Tsou, C.-L. (1962) Sci. Sin. (Engl. Ed.) 11, 1535-1558) which indicates that one essential histidine reacts approximately four times faster than the other (histidyl) residues. In sharp contrast with the phenomenon observed in connection with CO2 hydration and HCO3- dehydration, acrolein improves the catalytic efficiency of the enzyme toward p-nitrophenyl acetate hydrolysis and acetaldehyde hydration, with the relative activity increasing by approximately 12 and 34%, respectively. The widely differing effects imparted by the same reagent represent the first step toward differential control of the specificity of carbonic anhydrase II.

Acrolein↗

A colorimetric procedure to monitor the extent of crosslinking of proteins by bisimidoesters.

Reaction of proteins with bisimidoesters is one of the popular crosslinking techniques. The extent of the reaction cannot be followed directly using the commonly used free amino group-determining reagents ninhydrin and 2,4,6-trinitrobenzene sulfonic acid since they react with bisimidoesters. However, we found that the extent of amidination of protein could be followed colorimetrically by using 1-fluoro-2,4-dinitrobenzene.

Animals↗

[Synthesis of N-alpha-(arylsulfonyl-L-prolyl)- and N alpha-(benzyloxycarbonyl-L-prolyl)-D,L-4-amidinophenylalanine amides as inhibitors of thrombin].

N alpha substituted 4-cyanophenylalanines were prepared by reaction of the acid chloride, the activated ester and the mixed anhydride of Tos-Pro-OH, 2-naphthylsulfonyl-L-proline and Z-Pro-OH, respectively, with cyanophenylalanine. These acids were transferred into the amides via the 4-nitrophenyl esters or the mixed anhydrides. The cyano compounds were converted via the thioamides and the thioimidic esters into the amidines by common way. The exchange of the glycine residue by prolin in compounds former described caused a decreased antithrombin effect.

Chemical Phenomena↗

Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.

BMY25282, a newly designed analogue of mitomycin C (MMC) with the substitution of an amidine group at position 7 of MMC, can circumvent MMC resistance in a series of human colonic carcinoma cells that were selected for resistance to MMC (J.K.V. Willson et al., Cancer Res., 45:5281-5286, 1985). In this study MMC resistance was found to be associated with an inability of the resistant cells to activate MMC. However, both the MMC-sensitive and -resistant cells were observed to metabolize BMY25282 extensively in vitro to a reactive species capable of alkylating 4-(p-nitrobenzyl)pyridine (a trapping agent for activated drug). The results of these studies suggested that the deficient cellular reductive activating mechanism was associated with MMC resistance and that analogue BMY25282 was able to overcome this deficiency in MMC-resistant cells by virtue of its enhanced activation.

Animals↗

Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.

BMY 25282, a newly designed analogue of mitomycin C (MMC), was assessed for its non-cross-resistant cytotoxic and biochemical action against MMC-resistant human colon carcinoma cells. The analogue has an amidine substituted at position 7 of MMC and has a more efficient intracellular activation to its active species than MMC. In this study we demonstrated that BMY 25282 can overcome MMC resistance in a series of previously described human colon carcinoma cells resistant to MMC (Cancer Res., 44: 5880, 1984). The non-cross-resistance of the analogue in the model was confirmed in vivo by treating tumor xenograft-bearing athymic mice with equitoxic doses of MMC or BMY 25282. We further investigated the formation of interstrand DNA cross-link (IDC) formation by BMY 25282 and MMC. MMC-sensitive cells contained 3 to 8 times as many IDCs as resistant colon carcinoma cells, while no significant differences in IDCs were found between the MMC-sensitive or -resistant cells incubated with BMY 25282. When MMC-sensitive or -resistant cells were exposed to the 70% inhibition concentration of either MMC or BMY 25282, no differences were seen with respect to IDC formation. These studies demonstrate that BMY 25282 is able to overcome MMC resistance in a series of human colon carcinoma cells and that IDC formation in the MMC-sensitive or -resistant cells parallels cytotoxicity for both MMC and the analogue.

Animals↗

[Synthesis of N-alpha-benzyloxycarbonyl-4-amidinophenylalanine amides as thrombin inhibitors].

Based on 4-cyanophenylalanine, the title compounds had been obtained by benzyloxycarbonylation of the amino group, subsequent formation of the activated ester by 4-nitrophenol, its aminolysis and at least change of the cyano function to the amidine function via thiocarbamides and thioimid acid esters. The inhibitor effect against thrombin of the pyrrolidid 16 is analogous to those of the adequate N alpha-tosyl compound.

Chemical Phenomena↗

[Synthesis of N-alpha-(8-quinolinesulfonyl)-4-amidinophenylalanine amides as thrombin inhibitors].

The compounds mentioned in the title were prepared starting from 4-cyanophenylalanine by sulfonylation using 8-quinoline sulfonic acid chloride, formation of the 4-nitrophenylester, aminolysis of the latter and subsequent transformation of the cyano via the thiocarbamoyl and the thioimid acid ester into the amidine group. The antithrombin effect decreased by substituting the 1-naphthylsulfonyl by the 8-quinolinesulfonyl residue.

Chemical Phenomena↗

[Synthesis of N alpha-(benzoylglycyl)- and N alpha-(benzyloxycarbonylglycyl)-4-amidinophenylalanine amides as thrombin inhibitors].

The 4-nitrophenyl esters of hippuric acid and benzyloxycarbonylglycine had been aminolyzed by racemic 4-cyanphenylalanine into the compounds 3 and 4. After activation as 4-nitrophenyl esters and following reaction with amines the amides 7-14 were formed. These cyano compounds were converted into the amidines via the thioamides 15-22 and the thioimidic esters 23-30. The piperidide 35 was most effective against thrombin.

Antithrombins↗

[1,5-benzodiazepines. V. Synthesis of pyrazolo (3,4-b)(1,5)benzodiazepines and 5H-pyrimido(4,5-b)(1,5)benzodiazepines].

The reaction of 4-(dialkylamino)-1,3-dihydro-2H-1,5-benzodiazepin-2-ones (I a-c) with N,N-dimethylformamide in the presence of phosphorus pentachloride at room temperature gave rise to the formation of 4-(dialkylamino)-3-[(dimethylamino)methylene]-1,3-dihydro-2H-1,5-benzodiazepin- 2-ones (IX a-c) which were useful starting materials to achieve the synthesis of tricyclic 1,5-benzodiazepine derivatives. Actually (IX a), selected for the smallest steric hindrance of the 4-dialkylamino substituent, by reaction with hydrazines afforded pyrazolo[3,4-b][1,5]benzodiazepine derivatives whereas reaction with guanidine or amidines gave 5H-pyrimido-[4,5-b][1,5]benzodiazepine derivatives. The structure of isomeric N-methyl-pyrazoles (X c) and (XI a) and of N-phenylpyrazole (X b) were elucidated by comparison with compounds prepared by unequivocal chemical methods. Pharmacological evaluation of some of the products showed only generic CNS depressant activity.

Animals↗

[Covalent binding of 1-aminoadamantan derivatives to protein antigens using the isothiocyanate and the imidic acid ester procedures. Part 27: Immunosuppressive agent-antigen conjugates (author's transl)].

Because of the described immunosuppressive potency of 1-aminoadamantan, the authors prepared conjugates of N-substituted 1-aminoadamantan derivatives with human serum albumin (HSA) and bovine gamma globulin (BGG). To achieve covalent binding of 1-aminoadamantan (1) to HSA and BGG (following the isothiocyanate procedure), 1 was converted to the N-(p-isothiocyanatobenzoyl) derivative of 1-aminoadamantan (4) via the nitro compound (2) and the amino compound (3). The reaction of 4 with HSA and BGG yielded conjugates with thiourea structure. The imidic acid ester hydrochloride (7) and the thioimidic acid ester hydrochloride (11) were prepared from the N-(p-cyanobenzoyl) derivative of 1-aminoadamantan (6) and reacted with HSA and BGG to give conjugates with amidine structure.

Amantadine↗

[Study of substances analagous to dimaprit affecting gastric secretion in vitro].

In the present paper the authors describe the effects of Dimaprit analogs on guinea pig gastric mucosa "in vitro". This preparation, widely described by Holton and Spencer, is useful for studying the actions of stimulants and inhibitors which act directly on the oxyntic cells. Such compounds are weakly active as stimulants of H2-receptors and studied as antagonists fail in inhibiting acid secretion evoked by Dimaprit, the most specific H2-receptors agonist. In particular, the compound marked Ros 5 clarifies that the isothiourea group of Dimaprit simulates the amidine system only chemically but not pharmacologically. The different mechanism of Dimaprit and Histamine on H2-receptors has been discussed.

Animals↗

[Synthesis of N alpha-(tosyl-beta-alanyl)- and N alpha-(tosyl-epsilon-aminocapronyl)amidinophenylalanineamides as strongly effective inhibitors of thrombin].

The headline compounds were prepared for further determination of structure-activity-relationships. By conversion of cyanophenylalanines with the acidic chloride of tosyl-beta-alanine resp. tosyl-epsilon-aminocapronic acid and aminolysis of the following prepared p-nitrophenylic esters the cyano compounds would get the desired structure, which were converted over the thioamides and thioimidic esters in the amidines by the common way. At the preparation of epsilon-aminocapronic acid derivatives occurred difficulties because of simultaneous formation of the N-tosyl-epsilon-caprolactame. The preparation of corresponding aminobutyric acid derivatives wasn't possible. The prolongation of the C-chain of the branchless amino acid decreased the antithrombine effect.

Aminocaproates↗

Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.

The pharmacokinetics of a series of heterocyclic compounds substituted with amidino or imidazolinyl groups and showing trypanocidal and antileukemic activity has been studied in mice and rats using radiolabelled material and newly developed HPLC techniques. Trypanocidal compound 261/115 (2-Amidino-indole-6-carboxamidine) showed species differences in mice and rats, however, in mice no differences were detected after i.p. and s.c. administration. Terminal half-life was 2.4 h and 5 days in mice and rats, respectively. Trypanocidal compound 102/198 [2-(4-Amidinophenyl)indole-6-carboxamidine), DAPI) showed a terminal half-life of 60 days in rats. For both compounds excretion data were determined, accounting for less than 1% in bile in both cases, 36% and 7.5% in urine and 36% and 22.5% in faeces for 261/115 and 102/198, respectively. According to an organ balance and a computer fit of excretion data extensive tissue binding seems to be responsible for this long terminal half-life. This is also suggested by RBC/plasma partitioning data. Since biliary excretion is negligible, direct excretion into the gut might be responsible for the excretion in faeces. For other antileukemic diamidines as well as for analogous diimidazolinyl compounds consisting of two heterocyclic nuclei linked by a double bond plasma pharmacokinetics were determined in mice after i.p. administration. Their terminal half-lives ranged between 3.5 and 10.7 h. For all compounds studied multi-compartmental models could be established. In addition, it could be shown for 261/115 and 150/129 [E)-2.2'-Vinylenedi-1-benzofurane-5-carboxamidine) that their pharmacokinetics were not dose-dependent. In general, imidazolinyl compounds showed higher plasma levels than did their amidine analogues. This property seems to be related to their solubility. However, no correlation could be found between pharmacokinetic properties and antileukemic activity. Therefore other properties like DNA-binding, tissue distribution etc. should be considered in evaluating new strategies for the development of antileukemic compounds.

Animals↗

[Synthesis of N-alpha-(arylsulfonylglycyl)amidinophenylalanine amides as highly active inhibitors of thrombin].

The headline compounds were prepared from purified cyanophenylalanines after presenting arylsulfonylglycyl residues, activation of the carboxyl group by formation of the p- nitrophenylester followed by aminolysis and transfer of a cyano in an amidine function. Besides some esters and an acid were synthetized with the basic structure mentioned in the headline . The p-compounds with a cycloaliphatic amide component proved as "tight binding inhibitors". The greatest antithrombin effect shows N alpha-(2- naphthylsulphonylglycyl )-4- amidinophenylalaninpiperidi d with a Ki-value of 6 X 10(-9) mol/l using S-2238 as a substrate.

Phenylalanine↗

[Immunological and enzymatical activity after dimiimidoester fixation (author's transl)].

The paper is concerned with the capability of diimidoesteras as histochemical fixatives. findings of diimidoester-fixed human erythrocytes show the receptor activity these cells had retained. Due to these properties amidinated red cells proved well suited as storable immunosorbens for ensuing tests of haemagglutination. Following immunisation with horseradish peroxidase of rats, diimidoester-fixed plasma cells were highly reactive towards HRP in contrast to only moderately stained glutaraldehyde fixed cells.

Animals↗

A label selection procedure for determining the location of protein-protein interaction sites by cross-linking with bisimidoesters. Application to lactose synthase.

A procedure is described that is designed to identify the primary site of cross-linking by bisimidoesters of a component of an interacting protein system. It is based on the mutually exclusive nature of acetylation and amidination. The procedure has been applied to the regulatory protein of lactose synthase, alpha-lactalbumin. A sample of bovine alpha-lactalbumin was acetylated with a trace amount of high specific activity [3H]acetic anhydride to produce a population of protein molecules essentially all of which contain 0 to 1 acetyl group; partial labeling of all 13 amino groups was obtained. This material was mixed with bovine colostrum galactosyltransferase in the presence of Mn2+, UDP-glucose, and N-acetylglucosamine, at pH 8.0, to promote complex formation and was cross-linked with dimethyl 3,3'-dithiobispropionimidate. Covalently cross-linked alpha-lactalbumin-galactosyltransferase (1:1) complex with characteristic enzymic and other properties was purified from the reaction mixture, and the distribution of [3H]acetyl label on each amino group of the alpha-lactalbumin component was determined, using procedures similar to those described in previous differential labeling studies (Richardson, R., and Brew, K. (1980) J. Biol. Chem. 255, 3377-3385). In comparison with the original labeled sample used for cross-linking, the specific activity of tritium label in 10 amino groups showed little change, whereas the labeling of three groups was changed markedly. The acetyl moiety on the epsilon-amino groups of lysines 5 and 108 showed major decreases in specific activity while that of lysine 114 was greatly increased. Similar results were obtained when the cross-linking was performed under different conditions of temperature, and cross-linker concentration. As the changes in lysines 5 and 114 are similar to those observed in differential labeling, they are attributed to alterations in the affinity for galactosyltransferase resulting from acetylation of these groups. In contrast, lysine 108, which is not sufficiently close to the interaction site to be perturbed in differential labeling studies but is greatly decreased in tritium content in the cross-linked complex, appears to represent the major site through which alpha-lactalbumin is cross-linked to galactosyltransferase as a result of the exclusion of protein molecules acetylated in this position from covalent cross-linking. Studies with a homologous series of bisimidoesters indicate that lysine 108 is situated 6.1 to 7.3 A degrees from an amino group on galactosyltransferase in the cross-linked complex. The general utility of the procedure and the nature of the interaction site in lactose synthase are discussed.

Acetylation↗

[Synthesis of N alpha-(4-methylbenzoyl)-4-amidinophenyl-alaninamides and -esters].

To test their inhibitory activity against serine proteinases, especially thrombin, in comparison to the very potent N alpha-tosyl-4-amidinophenylalaninamides, the authors synthetized the compounds named in the title, which contain the p-toluoyl residue in place of the tosyl residue. These compounds were prepared from 4-cyanophenyl-alanine (1) by N-acylation to 2 and formation of the active ester 3 which was aminolyzed. The amides thus obtained were converted, via the thioamides and the thioimidic acid ester salts, to the amidine hydroiodides 16-19. The methyl ester 21 was afforded from 2 by means of the Pinner reaction.

Chemical Phenomena↗

Mass spectrometric studies of a modified active-site tetrapeptide from delta 5-3-ketosteroid isomerase of Pseudomonas testosteroni.

Examination of the product of affinity labeling of delta 5-3-ketosteroid isomerase (EC 5.3.3.1) of Pseudomonas testosteroni by the suicide substrate [7-3H]5,10-secoestr-5-yne-3,10,17-trione has demonstrated that the steroid becomes bound by an acid- and base-labile linkage to an active-site peptide representing residues 55-58 (H2N-Tyr-Ala-Asn-Ser-CO2H) of the primary structure (Penning, T. M., and Talalay, P. (1981) J. Biol. Chem. 256, 6851-6858). Upon release of the steroid by mild acid hydrolysis, the peptide is converted into a more basic structure while retaining its amino acid composition (as determined by conventional means). These findings were rationalized by postulating that the steroid is bound as an imido ester via the amide group of asparagine 57 and that the polypeptide backbone participates (via attack by nitrogen or oxygen) in the hydrolysis of this ester with the formation of a cyclic amidine or basic oxazine. By comparing the properties of the isolated tetrapeptide, from which the steroid has been removed, with those of synthetic H2N-Tyr-Ala-Asn-Ser-CO2H and H2N-Tyr-Ala-Asp-Ser-CO2H by electron impact and fast atom bombardment mass spectrometry, we now have evidence for the presence of an oxazine (5,6-dihydro-6-iminio-4H-1,3-oxazine) in the modified peptide. Our results draw attention to the hitherto unsuspected degree of nucleophilicity of the amide group of the side chain of asparagine and the participation of this group in the formation of an imido ester.

Amino Acid Sequence↗